Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hann

Showing results (211-220 of 239) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|February 1, 2006
Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trialsAnupama Rao, Robert K Hills, Charles Stiller, et al.
RSC Medicinal Chemistry|May 1, 2023
Reactive fragments targeting carboxylate residues employing direct to biology, high-throughput chemistryRoss P Thomas, Emma K Grant, Eleanor R Dickinson, et al.
American Journal of Health Behavior|May 20, 2003
Do adults change their lifestyle behaviors after a cancer diagnosis?Chris M Blanchard, Maxine M Denniston, Frank Baker, et al.
British Medical Journal (Clinical Research Ed.)|August 6, 1983
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trialI M Hann, H G Prentice, H A Blacklock, et al.
Journal of Medicinal Chemistry|October 15, 1993
A series of penicillin derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationshipsD C Humber, M J Bamford, R C Bethell, et al.
Histology and Histopathology|June 10, 2005
Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantationJ Thiele, H M Kvasnicka, H Dietrich, et al.
Lancet (London, England)|April 10, 1982
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patientsI M Hann, H G Prentice, R Corringham, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2017
Prediction of intracellular exposure bridges the gap between target- and cell-based drug discoveryAndré Mateus, Laurie J Gordon, Gareth J Wayne, et al.
Haematology and Blood Transfusion|January 1, 1987
Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985R E Marcus, D Catovsky, H G Prentice, et al.
Journal of Medicinal Chemistry|November 26, 1993
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazinesD G Livermore, R C Bethell, N Cammack, et al.
Pageof 24

Showing results (211-220 of 239) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|February 1, 2006
Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trialsAnupama Rao, Robert K Hills, Charles Stiller, et al.
RSC Medicinal Chemistry|May 1, 2023
Reactive fragments targeting carboxylate residues employing direct to biology, high-throughput chemistryRoss P Thomas, Emma K Grant, Eleanor R Dickinson, et al.
American Journal of Health Behavior|May 20, 2003
Do adults change their lifestyle behaviors after a cancer diagnosis?Chris M Blanchard, Maxine M Denniston, Frank Baker, et al.
British Medical Journal (Clinical Research Ed.)|August 6, 1983
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trialI M Hann, H G Prentice, H A Blacklock, et al.
Journal of Medicinal Chemistry|October 15, 1993
A series of penicillin derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationshipsD C Humber, M J Bamford, R C Bethell, et al.
Histology and Histopathology|June 10, 2005
Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantationJ Thiele, H M Kvasnicka, H Dietrich, et al.
Lancet (London, England)|April 10, 1982
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patientsI M Hann, H G Prentice, R Corringham, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2017
Prediction of intracellular exposure bridges the gap between target- and cell-based drug discoveryAndré Mateus, Laurie J Gordon, Gareth J Wayne, et al.
Haematology and Blood Transfusion|January 1, 1987
Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985R E Marcus, D Catovsky, H G Prentice, et al.
Journal of Medicinal Chemistry|November 26, 1993
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazinesD G Livermore, R C Bethell, N Cammack, et al.
Pageof 24